Literature DB >> 8605913

Transfer of ceftazidime and aztreonam resistance from nosocomial strains of Xanthomonas (Stenotrophomonas) maltophilia to a recipient strain of Pseudomonas aeruginosa ML-1008.

M Babálová, J Blahová, M Lesická-Hupková, V Krcméry, K Kubonová.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8605913     DOI: 10.1007/bf01691506

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Transferable resistance to beta-lactams in a nosocomial strain of Xanthomonas maltophilia.

Authors:  M Hupková; J Blahová; J Králiková; V Krcmery
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

2.  Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningosepticum.

Authors:  J Blahová; M Hupková; V Krcméry; K Kubonová
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

3.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

4.  In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.

Authors:  E Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

  4 in total
  3 in total

1.  Extended spectrum beta-lactamase reactions in Stenotrophomonas maltophilia.

Authors:  J Blahová; M Hupková-Lesická; K Králiková; V Krcméry
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

Review 2.  Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.

Authors:  M Denton; K G Kerr
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 3.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.